Pharma Q2 Results Preview: Johnson & Johnson And Novartis

 
• By Jessica Merrill and Kevin Grogan

The earnings season is on us again with two heavyweights of health care hoping to show strong second-quarter results, while giving a glimpse into their prospects for the second half of the year. It will be Novartis' first chance to talk with investors about a new US Senate report regarding the company's dealings with Trump lawyer Cohen.

Abacus
Early reporters Novartis & J&J to reveal their numbers • Source: Shutterstock

More from Earnings

More from Business